Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Total Liabilities (2021 - 2026)

Prokidney's (PROK) quarterly Total Liabilities came in at $26.2 million in Q2 2026, down 19.9% year-over-year from $32.7 million in Q2 2025, and down 11.8% quarter-over-quarter from $29.7 million in Q1 2026.

Analysis

Prokidney (PROK) Total Liabilities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Total Liabilities for 6 consecutive years, with $26.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Liabilities fell 19.9% year-over-year to $26.2 million in Q2 2026; TTM through Jun 2026 was $26.2 million, a 19.9% decrease from a year earlier, with the FY2025 full-year figure at $34.8 million, down 11.8% from the prior year.
  • Total Liabilities was $26.2 million for Q2 2026 at Prokidney, down from $29.7 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $39.4 million in Q4 2024 and troughed at $11.9 million in Q3 2022.
  • A 5-year average of $25.7 million and a median of $27.0 million in 2023 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities jumped 66264.83% in 2022 and dropped 19.9% in 2026, its largest moves.
  • Over 5 years, Total Liabilities stood at $13.1 million in 2022, then surged by 123.76% to $29.2 million in 2023, then soared by 34.98% to $39.4 million in 2024, then dropped by 11.8% to $34.8 million in 2025, then decreased by 24.73% to $26.2 million in 2026.
  • The last three Total Liabilities figures came in at $26.2 million (Q2 2026), $29.7 million (Q1 2026), and $34.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 141.52 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 904.22 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 179.49 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 521.30 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 661.05 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 318.91 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 126.72 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 1.66 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 132.83 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 26.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.18 Mn
Mar 31, 2026 29.68 Mn
Dec 31, 2025 34.78 Mn
Sep 30, 2025 33.27 Mn
Jun 30, 2025 32.68 Mn
Mar 31, 2025 36.08 Mn
Dec 31, 2024 39.44 Mn
Sep 30, 2024 31.33 Mn
Jun 30, 2024 26.80 Mn
Mar 31, 2024 24.73 Mn
Dec 31, 2023 29.22 Mn
Sep 30, 2023 23.62 Mn
Jun 30, 2023 27.28 Mn
Mar 31, 2023 14.17 Mn
Dec 31, 2022 13.06 Mn
Sep 30, 2022 11.87 Mn
Jun 30, 2022 15.63 Mn
Mar 31, 2022 13.11 Mn
Dec 31, 2021 13.38 Mn
Sep 30, 2021 7.76 Mn